Delivery Order SPE2DB24D3015-SPE2DB26FFWVD
Award Date 10/30/25
Potential Completion Date 10/31/25
Potential Value $3.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $5,198.70 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Creon is a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency, reflecting DLA's role in supplying...
- The Defense Logistics Agency awarded a $4,529.19 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of 36,000 units of Creon DR 100s capsules, with completion targeted for September 16, 2025. This firm fixed-price contract represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Creon is a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency, indicating this delivery...
- The Defense Logistics Agency awarded a $3,990.56 delivery order to AmerisourceBergen Drug Corp on July 9, 2025, for the supply of 36,000 units of Creon DR 100s capsules. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 10, 2025, and performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Creon is a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency and digestive disorders, representing a specialized...
- The Defense Logistics Agency awarded a delivery order valued at $25,167.42 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules under a firm fixed-price contract. The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive delivery order utilizing the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. Creon is a pancreatic enzyme replacement therapy used to treat pancreatic...
- The Defense Logistics Agency awarded a delivery order valued at $3,088.91 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100 mg capsules. This non-competitive, firm fixed price delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a child contract under a larger vehicle, this delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,616.16 to AmerisourceBergen Drug Corp for 24,000 unit capsules of Creon DR 100s, a pancreatic enzyme replacement therapy commonly prescribed for patients with pancreatic insufficiency. The contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award through open competition. Performance will be executed from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count bottles, valued at $9,164.04. This competitively awarded, firm fixed-price delivery order, with no set-aside designation, is scheduled for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the...
- The Defense Logistics Agency awarded a delivery order valued at $3,893.43 to AmerisourceBergen Drug Corp for 24,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-unit packaging. The contract is a firm fixed-price delivery order with an ultimate completion date of October 31, 2025, and was awarded on October 30, 2025. This award is non-set-aside and competitively awarded, reflecting AmerisourceBergen's capability to meet federal procurement requirements. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,272.54 to AmerisourceBergen Drug Corp for 24,000 unit capsules of Creon DR 100s, a pancreatic enzyme replacement therapy. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Creon DR 24,000 unit capsules (100 count) valued at $3,737.86 under a firm fixed-price contract. The award was made on May 23, 2025, with an ultimate completion date of May 27, 2025. This is a non-set-aside competitive award, and performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...